Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Michael Grey Insider Profile
4 Followers
Michael Grey, Director at BioMarin Pharmaceutical, holds 382.95K shares in Mirum Pharmaceuticals (Ticker: MIRM), holds 628.85K shares in Reneo Pharmaceuticals (Ticker: RPHM), holds 42.84K shares in BioMarin Pharmaceutical (Ticker: BMRN).
Profitable Transactions
2 out of 4 Profitable Transactions
Average Return
+11.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Michael Grey holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Sep 02, 2022 - Sep 02, 2023
Return:+92.00%
The most profitable trade made by Michael Grey
Michael Grey's Trading History
BioMarin Pharmaceutical
Mar 09, 2021
Director
Informative Sell
381.40K
$3.57M
Mirum Pharmaceuticals
Sep 14, 2023
Director
Uninformative Sell
467.46K
$9.85M
Reneo Pharmaceuticals
Jul 27, 2023
EC, Director
Uninformative Sell
―
$1.08M
Spruce Biosciences
―
EC, Director
―
―
Mirati Therapeutics
Jan 20, 2021
―
Uninformative Buy
―
$336.41K
Achillion Pharmaceuticals
―
―
―
$0.00
Horizon Therapeutics
Oct 06, 2023
―
Uninformative Sell
11.35M
$0.00
List of latest transactions for each holding click on a transaction to see Michael Grey's performance on stock
You May Also Like
Michael Grey insider profile FAQ
What is the percentage of profitable transactions made by Michael Grey?
The percentage of profitable transactions made by Michael Grey is 50%.
What is the average return per transaction made by Michael Grey?
The average return per transaction made by Michael Grey is 11.00%.
What stocks does Michael Grey hold?
Michael Grey holds: BMRN, MIRM, RPHM, SPRB, MRTX, ~ACHN, HZNP stocks.
What was Michael Grey’s latest transaction?
Michael Grey latest transaction was an Uninformative Sell of $467.46K.
What was Michael Grey's most profitable transaction?
Michael Grey’s most profitable transaction was an Informative Buy of RPHM stock on September 2, 2022. The return on the trade was 92.00%.
What is Michael Grey's role in BioMarin Pharmaceutical?
Michael Grey's role in BioMarin Pharmaceutical is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.